San Diego-primarily based Viking Therapeutics marked itself as a serious competitor in the weight loss drug current market in February right after revealing promising info from a mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when provided as a weekly injection As well as in March the